We found that, mechanistically, EI24 attenuated NF-κB activity by binding to the Complex I component TRAF2 and causing its lysosome-dependent degradation, thereby suppressing the transcription of pro-inflammatory genes that contribute to tumor progression. Here, TRAF2 is linked to neoplasm.